National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

anti-PSCA fully human monoclonal antibody MK4721
An IgG1k fully human monoclonal antibody directed against the human prostate stem cell antigen (PSCA) with potential antineoplastic activity. Anti-PSCA fully human monoclonal antibody MK4721 selectively targets and binds to PSCA, triggering complement-dependent cell lysis and antibody-dependent cell-mediated cytotoxicity in tumor cells expressing PSCA. PSCA is a glycosyl-phosphatidylinositol (GPI)-linked cell surface antigen found in cancers of the bladder, pancreas, and prostate. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Code name:AGS-PSCA



Previous:anti-p53 T-cell receptor-transduced peripheral blood lymphocytes, anti-PD-1 human monoclonal antibody MDX-1106, anti-PD-1 monoclonal antibody CT-011, anti-PD-L1 monoclonal antibody MDX-1105, anti-PLGF monoclonal antibody TB-403
Next:anti-thymocyte globulin, antibody-drug conjugate CR011-vcMMAE, antineoplaston A10, antineoplaston AS2-1, Antrin

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov